Insulin Degludec (U-100) Vials and Ustekinumab Subcutaneous Injection
Determining the interaction of Insulin Degludec (U-100) Vials and Ustekinumab Subcutaneous Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Vials-Ustell
- Insulin Degludec (U-100) Vials-UTA
- Insulin Degludec (U-100) Vials-UTA Capsules
- Insulin Degludec (U-100) Vials-UTAC tablets
- Insulin Degludec (U-100) Vials-UTI Relief
- Insulin Degludec (U-100) Vials-Utibron Neohaler
- Ustekinumab Subcutaneous Injection-Insulin Degludec (U-200) Prefilled Pens
- Ustekinumab Subcutaneous Injection-Insulin degludec and liraglutide
- Ustekinumab Subcutaneous Injection-Insulin degludec and liraglutide Subcutaneous
- Ustekinumab Subcutaneous Injection-Insulin degludec Subcutaneous
- Ustekinumab Subcutaneous Injection-Insulin detemir
- Ustekinumab Subcutaneous Injection-Insulin Detemir (Cartridges and Prefilled Syringes)